Lotus Pharmaceutical Co Ltd
TWSE:1795

Watchlist Manager
Lotus Pharmaceutical Co Ltd Logo
Lotus Pharmaceutical Co Ltd
TWSE:1795
Watchlist
Price: 281.5 TWD -1.23% Market Closed
Market Cap: 74.7B TWD
Have any thoughts about
Lotus Pharmaceutical Co Ltd?
Write Note

Lotus Pharmaceutical Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lotus Pharmaceutical Co Ltd
Net Income (Common) Peer Comparison

Comparables:
Y
3705
4746
1789
S
4119
1720

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Lotus Pharmaceutical Co Ltd
TWSE:1795
Net Income (Common)
NT$4B
CAGR 3-Years
42%
CAGR 5-Years
54%
CAGR 10-Years
N/A
Y
YungShin Global Holding Corp
TWSE:3705
Net Income (Common)
NT$1.1B
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
4%
Formosa Laboratories Inc
TWSE:4746
Net Income (Common)
NT$255.9m
CAGR 3-Years
-48%
CAGR 5-Years
N/A
CAGR 10-Years
2%
ScinoPharm Taiwan Ltd
TWSE:1789
Net Income (Common)
NT$403m
CAGR 3-Years
15%
CAGR 5-Years
5%
CAGR 10-Years
-7%
S
SCI Pharmtech Inc
TWSE:4119
Net Income (Common)
NT$138.5m
CAGR 3-Years
N/A
CAGR 5-Years
-24%
CAGR 10-Years
-4%
Standard Chem & Pharm Co Ltd
TWSE:1720
Net Income (Common)
NT$854.1m
CAGR 3-Years
10%
CAGR 5-Years
17%
CAGR 10-Years
11%

See Also

What is Lotus Pharmaceutical Co Ltd's Net Income (Common)?
Net Income (Common)
4B TWD

Based on the financial report for Jun 30, 2024, Lotus Pharmaceutical Co Ltd's Net Income (Common) amounts to 4B TWD.

What is Lotus Pharmaceutical Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
54%

Over the last year, the Net Income (Common) growth was -15%. The average annual Net Income (Common) growth rates for Lotus Pharmaceutical Co Ltd have been 42% over the past three years , 54% over the past five years .

Back to Top